FDA
approval
· 2020-06-23
FDA Approved: TERIFLUNOMIDE — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for a generic teriflunomide from Aurobindo Pharma Limited, enabling its marketing for multiple sclerosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)